Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases
about
Functional MRI for the prediction of treatment response in head and neck squamous cell carcinoma: potential and limitationsUsing magnetic resonance imaging and spectroscopy in cancer diagnostics and monitoring: preclinical and clinical approachesImproving tumour heterogeneity MRI assessment with histograms.Functional magnetic resonance imaging techniques and their development for radiation therapy planning and monitoring in the head and neck cancersContemporary Diagnostic Imaging of Oral Squamous Cell Carcinoma - A Review of Literature.Advances in the management of squamous cell carcinoma of the head and neck.Parametric contrast-enhanced ultrasound as an early predictor of radiation-based therapeutic response for lymph node metastases of nasopharyngeal carcinoma.Amide proton transfer-weighted imaging of the head and neck at 3 T: a feasibility study on healthy human subjects and patients with head and neck cancer.Correlation of a priori DCE-MRI and (1)H-MRS data with molecular markers in neck nodal metastases: Initial analysis.The use of dynamic tracer concentration in veins for quantitative DCE-MRI kinetic analysis in head and neck.Diagnosis of brain tumors using dynamic contrast-enhanced perfusion imaging with a short acquisition timeDCE-MRI for Pre-Treatment Prediction and Post-Treatment Assessment of Treatment Response in Sites of Squamous Cell Carcinoma in the Head and Neck.Predicting outcomes in radiation oncology--multifactorial decision support systemsEvaluation of Head and Neck Tumors with Functional MR Imaging.Texture analysis on parametric maps derived from dynamic contrast-enhanced magnetic resonance imaging in head and neck cancerPretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neckApplications and limitations of radiomicsMultimodality functional imaging using DW-MRI and 18F-FDG-PET/CT during radiation therapy for human papillomavirus negative head and neck squamous cell carcinoma: Meixoeiro Hospital of Vigo Experience.Assessing Tumor Oxygenation for Predicting Outcome in Radiation Oncology: A Review of Studies Correlating Tumor Hypoxic Status and Outcome in the Preclinical and Clinical SettingsMRI of metastasis-permissive microenvironments.Functional imaging for radiotherapy treatment planning: current status and future directions-a review.Dynamic Contrast-Enhanced MR Imaging in Head and Neck Cancer: Techniques and Clinical Applications.Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma.Multiparametric magnetic resonance imaging in mucosal primary head and neck cancer: a prospective imaging biomarker study.Comparison of DCE-MRI kinetic parameters and FMISO-PET uptake parameters in head and neck cancer patients.Potential Role of PET/MRI for Imaging Metastatic Lymph Nodes in Head and Neck Cancer.A review of the predictive role of functional imaging in patients with mucosal primary head and neck cancer treated with radiation therapy.Biological imaging in clinical oncology: radiation therapy based on functional imaging.Modelling tumour volume variations in head and neck cancer: contribution of magnetic resonance imaging for patients undergoing induction chemotherapy.Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck.The emerging potential of magnetic resonance imaging in personalizing radiotherapy for head and neck cancer: an oncologist's perspective.Apparent Diffusion Coefficient Histograms of Human Papillomavirus-Positive and Human Papillomavirus-Negative Head and Neck Squamous Cell Carcinoma: Assessment of Tumor Heterogeneity and Comparison with Histopathology.Dynamic contrast-enhanced MRI, diffusion-weighted MRI and 18F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.The principal of dynamic contrast enhanced MRI, the method of pharmacokinetic analysis, and its application in the head and neck region.Dynamic contrast-enhanced magnetic resonance imaging for pretreatment prediction of early chemo-radiotherapy response in larynx and hypopharynx carcinoma.Pharmacokinetic analysis based on dynamic contrast-enhanced MRI for evaluating tumor response to preoperative therapy for oral cancer.Assessment of diffusion parameters by intravoxel incoherent motion MRI in head and neck squamous cell carcinoma.TumourMetrics: a comprehensive clinical solution for the standardization of DCE-MRI analysis in research and routine use.Dynamic Contrast-Enhanced MRI-Derived Intracellular Water Lifetime (τ i ): A Prognostic Marker for Patients with Head and Neck Squamous Cell Carcinomas.Early Post-treatment Assessment of MRI Perfusion Biomarkers Can Predict Long-term Response of Lung Cancer Brain Metastases to Stereotactic Radiosurgery.
P2860
Q26740275-9C9ED851-1A22-452B-A5B4-56A99E6101E5Q26865120-EC7B2078-318C-48D0-A2C6-4B5D9FFE2713Q27693208-63D5F527-F98E-42C4-8064-4FFD45EFD361Q28075983-A00BAAC7-1906-4C12-A1BA-C53E9795F4D0Q33565054-6CF8C2D0-9DE8-45D6-A8C0-2A0791766E28Q33720431-E90BBFF3-9174-4026-B8BF-57A1F8E12ECDQ33933009-08F87A82-8C90-4869-A1CE-846DDACC6289Q34160964-42CC82A9-D5FA-4ADA-8A77-044436A3B1A3Q34172445-2C6CCA90-0E01-4A09-9C72-FCE7986A97A0Q34635573-6DA53B9E-DA94-4281-A09C-46EBA087F516Q35175935-E007E36F-214E-4443-BA38-41175DFD3F83Q35866622-E20BB365-799E-4E0A-8E74-89025FE3DFE1Q36014711-0B5ACADF-5320-473D-94AE-0BAFD97A3B84Q36330208-82F49869-74C6-4B20-AEA3-305C4946696AQ36515722-197A1259-D3D9-47B0-914B-5EE45A08270DQ36547400-ED4F8D2D-A266-4C00-B67F-D621FA78EBBFQ37052862-7425B446-7205-447C-9DFA-89B6CFFBBBFFQ37590957-E611A689-B1BB-4C74-BF4C-D96E037992ECQ37604088-4D382D73-17B7-4280-AB00-7AA0A45D47AAQ37951603-D732D5DD-008E-439D-9688-6D496D461780Q38397651-29C66270-6AB0-4FD1-A33B-1C8B61189364Q38597048-9BFCD55D-A496-4A5B-A4D0-9D4B197D87C0Q38618620-79C5B26D-952A-4AB2-8BC5-D287005751C9Q38685910-3345B0A9-CDE4-4CC6-BB13-B5BABB0DFA03Q38743120-0C264919-180A-40F4-A1C4-CE6AB127AA77Q38830809-9E6FA750-8857-4D9B-8602-E3AA9D6EFB4FQ38836743-9B059136-5508-4859-9DAD-0DBF2C078DC6Q38887987-401355C7-B19A-4432-88A5-93AC9000F5ABQ39145943-121AC900-2281-4959-B18B-A7983176F449Q39156367-5D12DF9A-65E4-4FAB-966E-97B361766CBDQ39159557-3C21DE26-C843-4364-AD7E-4EF078771B42Q40045139-4AFF3F68-35B3-4F6E-884E-AE2022531F46Q40890024-ECD60C3D-22C2-4178-B2AF-8BD9B9C102EBQ41643320-817D35AA-AAE6-437A-8C9F-7326890C4E37Q41919665-AD72EA44-F938-482B-9E5F-075FDCCF58C4Q45912968-079213B4-6A2F-4C8F-A701-2B633564E711Q46687391-0B333956-04C6-4E47-A8FF-819794A2953EQ47104951-86EC2741-0175-4346-A2F7-658B711A6313Q47793448-A25263D0-78AC-408D-ACA2-29F6BC0B0C9AQ47827501-26433597-67A1-474F-B514-98B8BE4277AF
P2860
Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Dynamic contrast-enhanced magn ...... patients with nodal metastases
@ast
Dynamic contrast-enhanced magn ...... patients with nodal metastases
@en
type
label
Dynamic contrast-enhanced magn ...... patients with nodal metastases
@ast
Dynamic contrast-enhanced magn ...... patients with nodal metastases
@en
prefLabel
Dynamic contrast-enhanced magn ...... patients with nodal metastases
@ast
Dynamic contrast-enhanced magn ...... patients with nodal metastases
@en
P2093
P2860
P1476
Dynamic contrast-enhanced magn ...... patients with nodal metastases
@en
P2093
Amita Shukla-Dave
Andre L Moreira
David G Pfister
Dennis Kraus
Eric Sherman
Hilda E Stambuk
Howard T Thaler
Jason A Koutcher
Matthew G Fury
Nancy Y Lee
P2860
P304
P356
10.1016/J.IJROBP.2011.03.006
P407
P577
2011-05-19T00:00:00Z